A review of clinical efficacy data supporting emergency use authorization for <scp>COVID</scp> ‐19 therapeutics and lessons for future pandemics-Reference-Cited by-同舟云学术

A review of clinical efficacy data supporting emergency use authorization for COVID ‐19 therapeutics and lessons for future pandemics

Published:2022-08-21 Issue:10 Volume:15 Page:2279-2292
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Yoo Seo‐Hyun¹,Kim Lauren¹^ORCID,Lu Michelle¹,Nagoshi Kira¹,Namchuk Mark N.²^ORCID

Affiliation:

1. Harvard College Cambridge Massachusetts USA

2. Department of Biological Chemistry and Molecular Pharmacology Blavatnik Institute, Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13384

Reference119 articles.

1. How did we get here? Short history of COVID ‐19 and other coronavirus‐related epidemics

2. Emergency Use Authorization.U.S. Food and Drug Administration2021. Accessed Septemeber 6 2021.https://www.fda.gov/emergency‐preparedness‐and‐response/mcm‐legal‐regulatory‐and‐policy‐framework/emergency‐use‐authorization

3. Emergency Use Authorizations of COVID-19–Related Medical Products

4. Medical Countermeasures Dispensing

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Wastewater Monitoring for Infectious Disease: Intentional Relationships between Academia, the Private Sector, and Local Health Departments for Public Health Preparedness;International Journal of Environmental Research and Public Health;2023-08-25

3. Investigation on the Essential Oils of the Achillea Species: From Chemical Analysis to the In Silico Uptake against SARS-CoV-2 Main Protease;Life;2023-01-30